Cortisone works, but the side effects demand a better plan

How to use cortisone in dogs and cats: What the evidence actually supports

Induction versus maintenance: two distinct phases

For skin and allergic conditions, the research distinguishes clearly between getting a flare under control and keeping it there. An induction period of 5-7 days is used to bring acute inflammation down, after which the dose should be stepped down to the lowest amount that holds the condition, ideally 0.25 mg/kg every 48-72 hours in dogs. Doses should never be given more frequently than every 48 hours once you are in the maintenance phase, specifically to reduce adrenal suppression. [8]

For acute atopic or flea-allergy dermatitis, the anti-inflammatory dose used in dogs is 0.5-1 mg/kg prednisolone per day, and the explicit purpose of this phase is to give you time to find and remove the allergen trigger, not to manage the condition indefinitely. [2]

Topical as an alternative to systemic

Where the condition allows it, topical hydrocortisone aceponate is worth considering before reaching for oral prednisolone. In flea-allergy dermatitis, topical application reduced pruritus by 94% after just two days, with systemic side effects uncommon due to low plasma bioavailability. [5]

Short-term use: what actually happens over 14 days

Fourteen days at 1 mg/kg daily did not produce significant changes in blood glucose or electrolytes in healthy dogs, so short-term use at anti-inflammatory doses carries less metabolic risk than is sometimes assumed. [6] That said, 90% of dogs on a 14-day course showed behavioural changes including increased thirst, urination, appetite, and vocalisation, so warn owners upfront rather than letting them be surprised. [7] The same data confirms that 97% of owners reported the condition was controlled, which tells you the trade-off is often considered worthwhile in the short term. [7]

Long-term use: monitoring is not optional

Long-term systemic glucocorticoid treatment carries a meaningful infection risk, urinary tract infections develop in up to 68% of animals on long-term therapy. Bacteriological culture is recommended every 3-6 months for any animal receiving long-term treatment. [9] Liver enzyme activity (ALP, ALT, gamma-glutamyl transferase) increases progressively during treatment, so liver function should be tracked alongside routine monitoring. [11]

Lifelong use: Addison’s disease

Dogs with hypoadrenocorticism (Addison’s disease) are a distinct category, they require lifelong glucocorticoid replacement, usually prednisone, with most also needing mineralocorticoid replacement (desoxycorticosterone pivalate or fludrocortisone) to maintain electrolyte balance and prevent adrenal crisis. This is replacement therapy, not anti-inflammatory dosing, and it is non-negotiable for survival. [4]

Where cortisone is not the right first choice

In anaphylaxis, the evidence does not support routine glucocorticoid use, epinephrine remains the primary treatment. Glucocorticoids may have a role in refractory anaphylaxis or where concurrent asthma is present, but should not be assumed to be the standard response to acute allergic emergencies. [12]

The principle that runs through all of this

The research is consistent: lowest effective dose, longest dosing interval that controls the condition, shortest course that achieves the goal, and active monitoring the moment treatment extends beyond the short term. [8, 9, 10]